Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with B-cell non-Hodgkin lymphoma

Perry, C; Luttwak, E; Balaban, R; Shefer, G; Morales, MM; Aharon, A; Tabib, Y; Cohen, YC; Benyamini, N; Beyar-Katz, O; Neaman, M; Vitkon, R; Keren-Khadmy, N; Levin, M; Herishanu, Y; Avivi, I

Avivi, I (corresponding author), Tel Aviv Sourasky Med Ctr, Dept Hematol, Tel Aviv, Israel.; Avivi, I (corresponding author), Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel.

BLOOD ADVANCES, 2021; 5 (16): 3053

Abstract

Patients diagnosed with B-cell non-Hodgkin lymphoma (B-NHL), particularly if recently treated with anti-CD20 antibodies, are at risk of severe COVID-1......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索